Partners
Ardelyx partners with leading biopharmaceutical companies, industry organizations, and community groups to support the development and commercialization of our medicines, advance innovation, expand patient access, and support the communities we live and work in.
Biopharmaceutical Partnerships
Kyowa Kirin Co. Ltd. (Japan) Strategic collaboration for the development and commercialization of tenapanor for cardiorenal diseases associated conditions, including hyperphosphatemia. Tenapanor is approved and marketed as PHOZEVEL® for the improvement of hyperphosphatemia in adult patients with chronic kidney disease (CKD) on dialysis in Japan.
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. (China) Exclusive license agreement for the development and commercialization of tenapanor for irritable bowel syndrome with constipation (IBS-C) and hyperphosphatemia associated with CKD in China. Tenapanor is approved and marketed under the Chinese trade name Wan Ti Le for patients with CKD on hemodialysis with hyperphosphatemia in China.
Industry & Advocacy Partnerships
As part of the biopharma industry, Ardelyx takes pride in being a member of organizations like MassBio, California Life Sciences, the Texas Healthcare and Bioscience, and BIO Affiliates in CA, TX, and PA. By engaging with these influential organizations, we are better positioned to contribute to innovation and improve patient outcomes.
Community Partnerships
As part of our commitment to broadening our community impact, Ardelyx is proud to partner with Life Science Cares Boston and Life Science Cares Bay Area. By joining this partnership, we become part of a broader, industrywide effort that pools resources and volunteer hours to support much‑needed programs and nonprofits, enabling us to make an even greater impact together.
The Ladies Professional Golf Association
Ardelyx is a corporate marketing partner of the Ladies Professional Golf Association (LPGA), collaborating on a multi-year initiative to help break the stigma around gastrointestinal conditions. Through this partnership, Ardelyx supports awareness and education efforts to elevate the understanding of IBS-C and encourage more open conversations among patients.
